NCT06323421

Brief Summary

Many neighborhoods in Chicago experience daily exposure to stressors including economic inopportunity and violent crime in public spaces. There is mounting evidence that chronic psychosocial stress can facilitate carcinogenesis by modulating the gut microbiome and immune system. The proposed research aims to study the practice of mindfulness to mitigate CPS and reduce colorectal cancer risk factors among Black American women at elevated risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
4 months until next milestone

Study Start

First participant enrolled

July 15, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 15, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

1 year

First QC Date

March 1, 2024

Last Update Submit

November 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Feasibility measures

    easible if ≥ 30% of those approached enroll at a minimum rate of 1-3 women/week for each wave and ≥ 80% of women enrolled are retained with complete data collection at both assessment time-point

    Monitored across the duration of study and 8-week intervention

  • Acceptability

    The intervention will be deemed acceptable if women attend ≥ 80% of the Mindfulness group sessions, engage with ≥ 80% of the asynchronous Mindfulness content and score ≥ 16 on the acceptability survey.

    Week 4 and post-intervention at week 9

Other Outcomes (14)

  • Body mass index

    Baseline and post-intervention at week 9

  • Stress measure

    Baseline and post-intervention at week 9

  • Fasting glucose

    Baseline and post-intervention at week 9

  • +11 more other outcomes

Study Arms (1)

Mindfulness

EXPERIMENTAL

8-week group and individual mindfulness training and practice

Behavioral: Mindfulness

Interventions

MindfulnessBEHAVIORAL

Participants attend seven 60-90 min group mindfulness sessions each week and a 1/2 day retreat, with three sessions in-person and six sessions remote, led by a mindfulness interventionist. Additionally, participants will be encouraged to engage for at least 30 minutes per week in asynchronous mindfulness activities through a web-based program to increase exposure to mindfulness practices beyond group sessions.

Mindfulness

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female based on sex assigned at birth
  • Self-identify as Black
  • Age 45-65 years old
  • Completed a colonoscopy in the past 24 months,
  • Classify as elevated risk of CRC defined as: any colorectal adenoma detected in past 24 months
  • Own and use a smartphone, computer, or tablet with access to the Internet
  • Score ≥ 14 on the PSS at screening
  • Reside in a Chicago community with high violent crime

You may not qualify if:

  • History of CRC
  • Antibiotics (oral/IV) in the past 2 months
  • Inflammatory bowel disease or genetic predisposition to CRC
  • Cancer diagnosis or cancer treatment in the past 12 months
  • Consume \> 50 grams of ethanol daily
  • Use combustible tobacco
  • Bariatric surgery or bowel resection
  • Immunodeficiency/autoimmune disease
  • Uncontrolled diabetes (HbA1c \> 9% based on EHR)
  • Fiber or pre-/probiotic supplements \> 3 days per week
  • Serrated adenoma at the recent colonoscopy given the molecular features are distinct
  • Significant health conditions or take medications that impact participation or expected outcomes (e.g., β-blocker, Cushing's syndrome, and corticosteroids - inhaled, topical, oral in the past month given effects on hair cortisol measurement)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Illinois Chicago

Chicago, Illinois, 60612, United States

Location

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 1, 2024

First Posted

March 21, 2024

Study Start

July 15, 2024

Primary Completion

July 15, 2025

Study Completion

August 31, 2025

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations